glp 1 agonist for type 1 diabetes GLP-1 Receptor Agonists as Treatments 2 GLP-1 Agonists Explained: Definition, How
Description
As with many of the options on this list, it is not FDA-approved for use as a weight loss medication

The hepato-enteral circulation theory of bile acids is well known

Nachnani JS, Bulchandani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Quinn T, Weide L, and Alba LM

Triple hormone receptor agonist retatrutide for obesity. New England Journal of Medicine
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
